Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF
- 1 February 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 116 (2), 468-474
- https://doi.org/10.1046/j.1365-2141.2002.03264.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignanciesBone Marrow Transplantation, 2000
- Peripheral Blood Stem Cell Mobilization for High-Dose ChemotherapyJournal of Hematotherapy, 1999
- Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myelomaBone Marrow Transplantation, 1998
- Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastimBritish Journal of Haematology, 1998
- Optimization of Peripheral Blood Stem Cell MobilizationThe International Journal of Cell Cloning, 1996
- High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.Journal of Clinical Oncology, 1994
- Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantationBritish Journal of Haematology, 1994
- High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftBlood, 1994
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988